Implications of genomic instability in the diagnosis and treatment of breast cancer

Identification of Aneuploidy-Selective Antiproliferation Compounds

(2011) Yun-Chi Tang et al.   CELL

Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer

(2011) Joyce O'Shaughnessy et al.   NEW ENGLAND JOURNAL OF MEDICINE

PTEN, PIK3CA, p-AKT, and p-p70S6K Status

(2010) Francisco J. Esteva et al.   AMERICAN JOURNAL OF PATHOLOGY

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

(2010) Henne Holstege et al.   BMC CANCER

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

(2010) N. Turner et al.   CANCER RESEARCH

Chromosomal instability: A composite phenotype that influences sensitivity to chemotherapy

(2010) Sarah E. McClelland et al.   CELL CYCLE

Pathologic Complete Response to Preoperative Sequential Doxorubicin/Cyclophosphamide and Single-Agent Taxane With or Without Trastuzumab in Stage II/III HER2-Positive Breast Cancer

(2010) Saranya Chumsri et al.   Clinical Breast Cancer

BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications

(2010) Rebecca J. Linger et al.   FEBS Journal

Deconstructing the molecular portraits of breast cancer

(2010) Aleix Prat et al.   Molecular Oncology

RB1CC1 Together with RB1 and p53 Predicts Long-Term Survival in Japanese Breast Cancer Patients

(2010) Tokuhiro Chano et al.   PLoS One

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

(2010) J. H. Taube et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis

(2009) Y. H. Choi et al.   ANNALS OF ONCOLOGY

AIB1 is a predictive factor for tamoxifen response in premenopausal women

(2009) S. Alkner et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Promoter methylation and the detection of breast cancer

(2009) Jennifer Brooks et al.   CANCER CAUSES & CONTROL

Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

(2009) S. E. Elsheikh et al.   CANCER RESEARCH

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

(2009) B. T. Hennessy et al.   CANCER RESEARCH

Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer

(2009) Carey K. Anders et al.   Clinical Breast Cancer

The effect of genetic variability on drug response in conventional breast cancer treatment

(2009) Emilia Wiechec et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Complex landscapes of somatic rearrangement in human breast cancer genomes

(2009) Philip J. Stephens et al.   NATURE

EBV and genomic instability—A new look at the role of the virus in the pathogenesis of Burkitt's lymphoma

(2009) Bettina Gruhne et al.   SEMINARS IN CANCER BIOLOGY

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

(2008) M. Rudas et al.   CLINICAL CANCER RESEARCH

Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer

(2008) Anuradha Poonepalli et al.   GENES CHROMOSOMES & CANCER

A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas

(2008) Emilia Wiechec et al.   GENES CHROMOSOMES & CANCER

Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer

(2008) Alexandros Daskalos et al.   INTERNATIONAL JOURNAL OF CANCER

HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer

(2008) Soonmyung Paik et al.   NEW ENGLAND JOURNAL OF MEDICINE

Defining ‘chromosomal instability’

(2008) Jochen B. Geigl et al.   TRENDS IN GENETICS

Telomere dysfunction, genome instability and cancer

(2007) Annie et al.   Frontiers in Bioscience-Landmark